Surgical Outcomes and Prognostic Factors in Patients With Diffuse Large B-cell Lymphoma-associated Metastatic Spinal Cord Compression

被引:14
|
作者
Han, Shuai [1 ]
Yang, Xinghai [1 ]
Jiang, Dongjie [1 ]
Zhou, Wang [1 ]
Liu, Tielong [1 ]
Yan, Wangjun [1 ]
Wang, Ting [1 ]
Cheng, Li [1 ]
Xiao, Jianru [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Bone Tumor Surg, Shanghai, Peoples R China
关键词
diffuse large B-cell lymphoma; metastatic spinal cord compression; prognostic factors; spinal decompression; stabilization; surgical outcomes; NON-HODGKINS-LYMPHOMA; PRIMARY BONE LYMPHOMA; CHEMOTHERAPY; CHOP;
D O I
10.1097/BRS.0000000000001511
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A retrospective study. Objective. The aim of this study was to discuss the factors that may affect surgical outcomes of patient with diffuse large B-cell lymphoma (DLBCL)-associated metastatic spinal cord compression (MSCC). Summary of Background Data. DLBCL in the spine is rare and minimal information has been published in the literature regarding this subject. Although DLBCL is highly sensitive to both chemotherapy and radiotherapy, surgical decompression is recommended in the treatment of DLBCL-associated MSCC. However, the prognostic factors affecting surgical outcomes of patients with DLBCL-associated MSCC remain unknown. Methods. We conducted a retrospective study to investigate the impact of surgical decompression on recovery from neurological deficit caused by DLBCL-associated MSCC. Univariate and multivariate analyses were performed to identify prognostic factors for overall survival of spinal DLBCL. The survival rate was estimated by the Kaplan-Meier method, and differences were analyzed by the log-rank test. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis. Results. A total of 37 patients with spinal DLBCL from 2003 to 2014 were included in the study. International Prognostic Index (IPI) (0-1/2-5), duration of preoperative symptoms (<= 2m/>2m), and lactate dehydrogenase (normal/abnormal) were suggested as the potential prognostic factors through univariate analysis. However, as they were submitted to the multivariate Cox regression model, only IPI and duration of preoperative symptoms were found as independent prognostic factors. Conclusion. Surgical decompression improves recovery from neurological deficit. Patient IPI score plays an important role in decision making for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.
引用
收藏
页码:E943 / E948
页数:6
相关论文
共 50 条
  • [21] An Investigation of Potential Prognostic Factors in Late Relapse Diffuse Large B-Cell Lymphoma Patients
    Robinson, Wilton Edward, Jr.
    Zhang, Yuzi
    Chen, Zhengjia
    Calzada, Oscar
    Churnetski, Michael C.
    Flowers, Christopher
    Cohen, Jonathon B.
    BLOOD, 2017, 130
  • [22] Prognostic biomarkers in diffuse large B-cell lymphoma
    Lossos, IS
    Morgensztern, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 995 - 1007
  • [23] Prognostic markers in diffuse large B-cell lymphoma
    Delabie, Jan
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1588 - 1589
  • [24] Molecular and Immunophenotypic Prognostic Factors of Diffuse Large B-cell Lymphoma in Malawi
    Fedoriw, Yuri
    Montgomery, Nathan
    Selitsky, Sara
    Tomoka, Tamiwe
    Dhungel, Bal
    Mulenga, Maurice L.
    Parker, Joel
    Gopal, Satish
    LABORATORY INVESTIGATION, 2018, 98 : 515 - 515
  • [25] Molecular and Immunophenotypic Prognostic Factors of Diffuse Large B-cell Lymphoma in Malawi
    Fedoriw, Yuri
    Montgomery, Nathan
    Selitsky, Sara
    Tomoka, Tamiwe
    Dhungel, Bal
    Mulenga, Maurice L.
    Parker, Joel
    Gopal, Satish
    MODERN PATHOLOGY, 2018, 31 : 515 - 515
  • [26] Diffuse large B-cell lymphoma - a new look and old prognostic factors
    Dobrea, Camelia
    Al Salamat, Hamed
    Lupu, Anca Roxana
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2012, 20 (04): : 307 - 315
  • [27] Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma
    Ken-ichi Miyamoto
    Yukio Kobayashi
    Akiko Miyagi Maeshima
    Hirokazu Taniguchi
    Junko Nomoto
    Hideaki Kitahara
    Suguru Fukuhara
    Wataru Munakata
    Dai Maruyama
    Kensei Tobinai
    International Journal of Hematology, 2016, 103 : 693 - 702
  • [28] Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma
    Miyamoto, Ken-ichi
    Kobayashi, Yukio
    Maeshima, Akiko Miyagi
    Taniguchi, Hirokazu
    Nomoto, Junko
    Kitahara, Hideaki
    Fukuhara, Suguru
    Munakata, Wataru
    Maruyama, Dai
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (06) : 693 - 702
  • [29] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [30] Prognostic factors in diffuse large B-cell lymphoma at diagnosis (international prognostic index excluded)
    Calvani, Julien
    Meignin, Veronique
    Vercellino, Laetitia
    Thieblemont, Catherine
    HEMATOLOGIE, 2021, 27 : 5 - 17